International Health Insurance News: Targeted cancer treatment developed - Sign up to our mailing list
best live chat
Quick Quote
  • (inc. country & area code)
  • Please note this service is only available during London office hours. If your call is urgent we will endeavour to get back to you at the earliest possible opportunity.
  • This field is for validation purposes and should be left unchanged.

International Health Insurance News: Targeted cancer treatment developed

In news that could be of interest to international health insurance customers, scientists have developed a way of delivering cancer treatment to targeted areas.

Professor Sylvain Martel, director of the Nanorobotics Laboratory at Polytechnique Montreal, made the breakthrough, which will allow doctors to deliver cancer drugs without harming healthy tissue in the body.

The professor came up with the method using therapeutic magnetic microcarriers, which were developed under his joint direction with Professor Jean-Christophe Leroux by Pierre Pouponneau.

Microcarriers are of use because they are able to encapsulate a dose of the therapeutic agent, which was doxorubicin in this case, as well as magnetic nanoparticles.

These magnetic nanoparticles can then be guided by an upgraded MRI system through the body's blood vessels to treat the targeted cancerous cells.

International health insurance customers could soon be benefiting from this treatment as the patent for the technology has just been issued in the US.

Expatriate Healthcare specialise in providing international health insurance. Make sure you're protected.

© Expatriate HealthcareADNFCR-1788-ID-800465651-ADNFCR

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+Email this to someone
South AmericaNorth AmericaAfricaAustralia & New ZealandAsiaEurope